In Post #41683 i began to describe things i was seeing that suggested that things going on here were not as they seemed to me. That maybe these are not hostile parties attacking SINT but related parties attacking SINT. It began with someone trying to get me to sell days before Sintx announced the offering price in Feb 2023 as described in my previous post. How did this account know about the forthcoming offering? Then there were several posts summer of 2023 indicating that SIntx would follow the same path as Sonny's friend over at ConforMIS as Confor went private way undervalued for reasons i honestly havent looked into. However there have been two main things that have really had me concerned.
The first one is that despite talking to me about range of subjects and companies, these social media accounts (Atlanta1, JoeV2, Madg, MicTraderetc..) avoid talking about 1 specific company. That company is NP Aerospace, a company i have recently showed to be likely partner based on both companies working on female specific body armor at the same time. It was only in claiming several times that these accounts cant talk about NP Aerospace that they even would mention that company, albeit barely & briefly. If they cannot truly discuss this company it means they are somehow bound not to or fear they might incriminate themselves/ reveal truth if they did. If they do not want to lie or fear revealing truth, that means they are aware of more thats going on and thus represent one of the parties involved. This while the bulk of their posts are skewed very negatively against Sintx.
Related to this, back in August i began to increase my claims about Sintx & NP Aerospace's relationship. Shortly afterwards Sintx announced the closing of its Salt Lake city armor facility. While the timing is a little suspect and interesting, not to mentioned rushed as they made this decision the day before the Q2 filing, it fits with their cost cutting measures. However there are two aspects to this that suggests that the company and the previous named posters do not want me to discuss Sintx and NP Aerospace. Firstly the company did not indicate what direction it was going in regards to manufacturing armor since it was closing the SLC facility. This suggests that its plans in regards to this subject are undisclosable material information. Then there was a post by Atlanta1 with the paragraph about Sintx shutting down its SLC armor facility that was posted within a half an hour of the 10Q filing. This despite the quote being on page 18 of the filing...almost as if he knew it was there. The mocking tone to his post suggests he wanted me to believe that Sintx was exiting the armor market , which he later tried to say was true, and that would mean it wasnt working with NP Aerospace. This despite no indication from the company that it had any intention to exit the armor market. This was implied with his roflmfao post # 41436 linked below in response to my post calling out JoeV2 cop-out in his post claiming he doesnt care enough to talk about Sintx-NP Aerospace. As it turns out, Sintx has a second armor manufacturing facility in Maryland at one of its TA&T buildings providing an alternative facility.
The next concerning thing was in April of 2024 when specific accounts, again this is covered in my previous post, tried to get me to post on Cafepharma by posting about it here while also trying to goad me there. When they did this i began to suspect that they were trying to repeat their previous methods back in 2018. Namely to get me to post about Sintx and Zimmer Biomet to potentially distract from other possible strategic maneuvers. If this was in fact the game they were playing that means what was to be announced a couple months later, did not have to do with Zimmer Biomet and they already knew it. Another reason for them to want me to talk about Sintx and Zimmer Biomet is so they can try to reinforce that Im trying to scam people and there is nothing going on between Sintx and Zimmer Biomet despite close to 20 years of them working together.
Yes i do think Zimmer Biomet will come out from behind the curtain one day, just not yet based on what im seeing.
That brings me to another point, they do not like me talking about Amylin Pharma and Eli Lilly. Why would that be? Amylin and Sintx share a lot of parallels and what occurred with Amylin maybe similar to what will happen with Sintx.
Both Amylin and Sintx were founded by people connected to the companies they eventually partnered with. Sintx was co-founded by Dr Hofmann, MD who was a surgeon designer for Centerpulse/Zimmer. Amylin founded by Howard Greene Jr who just sold a company to Eli the year prior. Like Amylin, Sintx had two board members with ties to Zimmer in Dr Link, PHD who was Chairman from 2003-2014, & Dr Sonny Bal, MD. Dr Link was CEO of Centerpulse for its deal with Zimmer. Dr Bal was on Zimmer's scientific panel doing work for them since 2002 up until at least 2014 according to Dr Bal's 2014 resume. Former Eli Lilly executives were on Amylin's board: Joseph Cook who became CEO & Chairman like Sonny Bal, and Gringer Graham who became CEO after Cook stepped down as CEO but remained Chairman.
Anyways, Eli Lilly eventually partnered with Amylin just like Biomet/Zimmer Biomet partnered with Sintx; difference here is theres been no official disclosure of Sintx and Biomet/Zimmer Biomet's partnership only inferred partnerships through joint IP testing. However Eli Lilly did not acquire Amylin in the end, Bristol Myers does. Ok, that happens right? Well, whats particularly interesting is Eli doesnt acquire its partner Amylin in 2008 but instead acquires Bristol Myers partner ImClone with Carl Icahn being the one that helped broker that deal. Then Mr Icahn removes Eli Lilly board members on Amylin and oversees the sell of Amylin to Bristol Myers in 2012. What that suggests to me is a deal was made behind the scenes at some point for Eli and Bristol Myers to acquire each others partners, drug swap, and Carl Icahn worked as the public face of the deal. There are more details here to support this like Eli Lilly no longer needing Amylins drugs because of ImClones drugs but also in Amylins board not wanting to sell yet in 2009 because it believed that shareholders would not get sufficient value at that time.
This has me wondering, do people not like me posting about Amylin/Eli Lilly because a similar type of deal was orchestrated years ago? It would not be the same i'll acquire yours and you acquire mine type scenario. If Sintx and NP Aerospace merge in any way then its possible an agreement was made between Zimmer Biomet and Morgan Ceramics behind the scenes which led Morgan to divest NP and Sintx to divest Amedica at the same time. In parallel to that Zimmer Biomet was getting ready to divest Spine/Dental IP like Sintx did. I see this going a couple different directions. Zimmer Biomet could acquire this newly merged company and become more like J&J or it could simply acquire IP from the merged company injecting NP with alot of capital to further fund its expansion within the defense markets. Zimmer Biomet needs to diversify itself as pandemics hurt its business more than other major ortho companies. I feel Sintx is sufficient in helping Zimmer Biomet diversify its portfolio given all the significant markets Sintx IP can be used in. However i do not know Zimmer Biomets longterm plans.
I am getting ahead of myself here as I need to cover a major variable thats been at play since 2015. Anson and its family of hedge funds. Whats particularly interesting is this family of funds were shorting/distorting/participating in offerings from 2015-2018. Then pickup at an accelerated pace in 2023 although theres signs they were working the price in 2022 as well. The period of 2019-2022 when this group of funds was not obvious in their participation in offerings, Sintx was gearing up to supply the defense markets getting AS9100D certified and acquiring armor assets/TA&T facility. Interestingly as soon as the TA&T deal was done Sintx stockprice began its rapid descent. I'll go more into all this in a followup post.
Post # 41436
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174914418
The first one is that despite talking to me about range of subjects and companies, these social media accounts (Atlanta1, JoeV2, Madg, MicTraderetc..) avoid talking about 1 specific company. That company is NP Aerospace, a company i have recently showed to be likely partner based on both companies working on female specific body armor at the same time. It was only in claiming several times that these accounts cant talk about NP Aerospace that they even would mention that company, albeit barely & briefly. If they cannot truly discuss this company it means they are somehow bound not to or fear they might incriminate themselves/ reveal truth if they did. If they do not want to lie or fear revealing truth, that means they are aware of more thats going on and thus represent one of the parties involved. This while the bulk of their posts are skewed very negatively against Sintx.
Related to this, back in August i began to increase my claims about Sintx & NP Aerospace's relationship. Shortly afterwards Sintx announced the closing of its Salt Lake city armor facility. While the timing is a little suspect and interesting, not to mentioned rushed as they made this decision the day before the Q2 filing, it fits with their cost cutting measures. However there are two aspects to this that suggests that the company and the previous named posters do not want me to discuss Sintx and NP Aerospace. Firstly the company did not indicate what direction it was going in regards to manufacturing armor since it was closing the SLC facility. This suggests that its plans in regards to this subject are undisclosable material information. Then there was a post by Atlanta1 with the paragraph about Sintx shutting down its SLC armor facility that was posted within a half an hour of the 10Q filing. This despite the quote being on page 18 of the filing...almost as if he knew it was there. The mocking tone to his post suggests he wanted me to believe that Sintx was exiting the armor market , which he later tried to say was true, and that would mean it wasnt working with NP Aerospace. This despite no indication from the company that it had any intention to exit the armor market. This was implied with his roflmfao post # 41436 linked below in response to my post calling out JoeV2 cop-out in his post claiming he doesnt care enough to talk about Sintx-NP Aerospace. As it turns out, Sintx has a second armor manufacturing facility in Maryland at one of its TA&T buildings providing an alternative facility.
The next concerning thing was in April of 2024 when specific accounts, again this is covered in my previous post, tried to get me to post on Cafepharma by posting about it here while also trying to goad me there. When they did this i began to suspect that they were trying to repeat their previous methods back in 2018. Namely to get me to post about Sintx and Zimmer Biomet to potentially distract from other possible strategic maneuvers. If this was in fact the game they were playing that means what was to be announced a couple months later, did not have to do with Zimmer Biomet and they already knew it. Another reason for them to want me to talk about Sintx and Zimmer Biomet is so they can try to reinforce that Im trying to scam people and there is nothing going on between Sintx and Zimmer Biomet despite close to 20 years of them working together.
Yes i do think Zimmer Biomet will come out from behind the curtain one day, just not yet based on what im seeing.
That brings me to another point, they do not like me talking about Amylin Pharma and Eli Lilly. Why would that be? Amylin and Sintx share a lot of parallels and what occurred with Amylin maybe similar to what will happen with Sintx.
Both Amylin and Sintx were founded by people connected to the companies they eventually partnered with. Sintx was co-founded by Dr Hofmann, MD who was a surgeon designer for Centerpulse/Zimmer. Amylin founded by Howard Greene Jr who just sold a company to Eli the year prior. Like Amylin, Sintx had two board members with ties to Zimmer in Dr Link, PHD who was Chairman from 2003-2014, & Dr Sonny Bal, MD. Dr Link was CEO of Centerpulse for its deal with Zimmer. Dr Bal was on Zimmer's scientific panel doing work for them since 2002 up until at least 2014 according to Dr Bal's 2014 resume. Former Eli Lilly executives were on Amylin's board: Joseph Cook who became CEO & Chairman like Sonny Bal, and Gringer Graham who became CEO after Cook stepped down as CEO but remained Chairman.
Anyways, Eli Lilly eventually partnered with Amylin just like Biomet/Zimmer Biomet partnered with Sintx; difference here is theres been no official disclosure of Sintx and Biomet/Zimmer Biomet's partnership only inferred partnerships through joint IP testing. However Eli Lilly did not acquire Amylin in the end, Bristol Myers does. Ok, that happens right? Well, whats particularly interesting is Eli doesnt acquire its partner Amylin in 2008 but instead acquires Bristol Myers partner ImClone with Carl Icahn being the one that helped broker that deal. Then Mr Icahn removes Eli Lilly board members on Amylin and oversees the sell of Amylin to Bristol Myers in 2012. What that suggests to me is a deal was made behind the scenes at some point for Eli and Bristol Myers to acquire each others partners, drug swap, and Carl Icahn worked as the public face of the deal. There are more details here to support this like Eli Lilly no longer needing Amylins drugs because of ImClones drugs but also in Amylins board not wanting to sell yet in 2009 because it believed that shareholders would not get sufficient value at that time.
This has me wondering, do people not like me posting about Amylin/Eli Lilly because a similar type of deal was orchestrated years ago? It would not be the same i'll acquire yours and you acquire mine type scenario. If Sintx and NP Aerospace merge in any way then its possible an agreement was made between Zimmer Biomet and Morgan Ceramics behind the scenes which led Morgan to divest NP and Sintx to divest Amedica at the same time. In parallel to that Zimmer Biomet was getting ready to divest Spine/Dental IP like Sintx did. I see this going a couple different directions. Zimmer Biomet could acquire this newly merged company and become more like J&J or it could simply acquire IP from the merged company injecting NP with alot of capital to further fund its expansion within the defense markets. Zimmer Biomet needs to diversify itself as pandemics hurt its business more than other major ortho companies. I feel Sintx is sufficient in helping Zimmer Biomet diversify its portfolio given all the significant markets Sintx IP can be used in. However i do not know Zimmer Biomets longterm plans.
I am getting ahead of myself here as I need to cover a major variable thats been at play since 2015. Anson and its family of hedge funds. Whats particularly interesting is this family of funds were shorting/distorting/participating in offerings from 2015-2018. Then pickup at an accelerated pace in 2023 although theres signs they were working the price in 2022 as well. The period of 2019-2022 when this group of funds was not obvious in their participation in offerings, Sintx was gearing up to supply the defense markets getting AS9100D certified and acquiring armor assets/TA&T facility. Interestingly as soon as the TA&T deal was done Sintx stockprice began its rapid descent. I'll go more into all this in a followup post.
Post # 41436
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174914418
Strawman Sockpuppet bot posting disinfo in relation to info in my posts.
Could it be that there is a strategy to distract people away from looking at basic data?
Is it an exercise to create forum verbiage to drown out any serious discussion of evidence?
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
